United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$790Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
RA Capital Management
Wellington Management
Perceptive Advisors
Janus Henderson Investors
Cormorant Asset Management
Eli LillySource recorded
Reported by IdigitalhealthSEC filing: $101M sold, first sale Nov 2019
From the SEC filings it signed: 5 on the team.
On the board, as filediCarsten Michael BoessEdward Michael KayeJean Michael KimNoreen Michael HenigTamar Michael ThompsonTroy Michael Wilson
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
These 2 firms list Avidity Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Avidity Biosciences's investors include Perceptive Advisors, Cormorant Asset Management, RA Capital Management, Wellington Management and Janus Henderson Investors, and 4 more on record.
Avidity Biosciences has raised $790M across 2 rounds since 2019.
Avidity Biosciences's most recent round was an Undisclosed round of $690M in Sept 2025.
Its most recent round, $690M in Sept 2025, is also its largest on record.
Avidity Biosciences's first round on record, in Nov 2019, was backed by Perceptive Advisors, Cormorant Asset Management and Logos Capital and 2 others.
Avidity Biosciences's latest named round is an Undisclosed round, in Sept 2025.
Avidity Biosciences is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
